Published in Drug Metab Dispos on April 25, 1979
Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate. Drug Metab Dispos (1976) 2.23
Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency. Br J Clin Pharmacol (1979) 2.01
Pharmacologic studies of indoramin in man. Clin Pharmacol Ther (1972) 1.72
Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev Med Child Neurol (1994) 1.63
Intonational disambiguation in sentence production and comprehension. J Psycholinguist Res (2000) 1.60
A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med (1992) 1.42
Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug. Drug Metab Dispos (1990) 1.25
Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent. Br J Pharmacol (1972) 1.13
Pharmacokinetics of methyldopa in man. J Pharmacol Exp Ther (1976) 1.10
Hypotensive ischemic optic neuropathy and peritoneal dialysis. Am J Ophthalmol (1999) 1.09
Preliminary studies on the pharmacology of an antidysrhythmic, Kö 1173, in man. Br J Pharmacol (1973) 1.09
Reversal of competitive neuromuscular blockade by RX 67668 in normal volunteers. Br J Pharmacol (1972) 1.09
Therapeutic pancreatic endoscopy after Whipple resection requires rendezvous access. Endoscopy (2009) 1.07
Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous use. Fundam Clin Pharmacol (1992) 1.07
Aphakic retinal detachment. Br J Ophthalmol (1985) 1.06
Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metab Dispos (1975) 1.05
In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase. Drug Metab Dispos (1990) 1.03
Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man. J Pharmacokinet Biopharm (1976) 1.03
Ranitidine: single dose pharmacokinetics and absolute bioavailability in man. Br J Clin Pharmacol (1982) 1.02
The physiological disposition of lovastatin. Drug Metab Dispos (1989) 1.00
Use of plasma levels in evaluation of procainamide dosage. Br Heart J (1974) 0.99
Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness. Postgrad Med J (1974) 0.99
Metabolism of carbidopa (1-(-)-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate), an aromatic amino acid decarboxylase inhibitor, in the rat, rhesus monkey, and man. Drug Metab Dispos (1974) 0.99
Interobserver variability in the interpretation of pulmonary artery catheter pressure tracings. Chest (1991) 0.98
The effects of probenecid upon the individual components of indomethacin elimination. J Pharmacol Exp Ther (1977) 0.97
Carnitine and glucuronic acid conjugates of pivalic acid. Xenobiotica (1985) 0.95
The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology (Berl) (2007) 0.95
Myocardial effects of indoramin hydrochloride, a new hypotensive agent. Br J Pharmacol (1971) 0.94
Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans. Br J Clin Pharmacol (1977) 0.93
Carcinoid tumor of the hepatic duct presenting as a Klatskin tumor in an adolescent and review of world literature. Hepatogastroenterology (2000) 0.90
Transbronchial needle aspiration staging of bronchogenic carcinoma. Am Rev Respir Dis (1986) 0.89
Potential false positive mediastinal transbronchial needle aspiration in bronchogenic carcinoma. Chest (1984) 0.88
Interaction between diflunisal and warfarin. Clin Pharmacol Ther (1980) 0.88
Qualitative determination of senna in urine. Lancet (1978) 0.87
Plasma-fluphenazine concentrations after injection of long-acting esters. Lancet (1978) 0.86
Retinal detachment following Nd:YAG posterior capsulotomy. Eye (Lond) (1987) 0.86
Diflunisal renal clearance in anesthetized dogs: effect of probenecid, urine flow, and urine pH. Arch Int Pharmacodyn Ther (1978) 0.84
The diagnosis and surgical management of acquired bilateral superior oblique palsy. Eye (Lond) (1987) 0.84
Molecular biology of circulatory shock. Part II. Expression of four groups of hepatic genes is enhanced after resuscitation from cardiogenic shock. Surgery (1990) 0.84
Food hypersensitivity in 30 dogs. J Am Vet Med Assoc (1986) 0.84
Uricosuric properties of diflunisal in man. Br J Clin Pharmacol (1979) 0.84
Cutaneous atypical mycobacteriosis in cats. J Am Vet Med Assoc (1983) 0.83
Further studies on the metabolism of carbidopa, (minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate, in the human, Rhesus monkey, dog, and rat. J Med Chem (1975) 0.83
Rat lung glutathione release: response to oxidative stress and selenium deficiency. J Appl Physiol (1985) (1987) 0.83
In vitro and in vivo studies on the metabolism of tirofiban. Drug Metab Dispos (1999) 0.83
Altered pharmacokinetics of oral flecainide by cimetidine. Br J Clin Pharmacol (1986) 0.82
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man. Br J Clin Pharmacol (1979) 0.82
Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys. Drug Metab Dispos (1983) 0.81
Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man. J Pharmacokinet Biopharm (1978) 0.81
Metabolic disposition of simvastatin in patients with T-tube drainage. Drug Metab Dispos (1994) 0.81
Human pharmacology of indoramin. Br J Pharmacol (1971) 0.81
Mesenteric vasoconstriction in cardiogenic shock in pigs. Gastroenterology (1992) 0.81
Effect of aluminum hydroxide on diflunisal absorption. Br J Clin Pharmacol (1979) 0.81
Stability study on specimens mailed to a state laboratory and tested with the Gen-Probe PACE 2 assay for chlamydia. Sex Transm Dis (1999) 0.81
Human pharmacokinetics of two crystalline and galenic forms of diflunisal, a new analgesic. Pharm Acta Helv (1978) 0.81
Botulinum toxin therapy for squint. Eye (Lond) (1988) 0.81
Tinted contact lenses as an alternative management for photophobia in stationary cone dystrophies in children. J AAPOS (2006) 0.81
Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase-activating protein inhibitor. Clin Pharmacol Ther (1994) 0.80
Physiological disposition of HMG-CoA-reductase inhibitors. Drug Metab Rev (1990) 0.80
The influence of diflunisal on the pharmacokinetics of oxazepam. Br J Clin Pharmacol (1985) 0.80
Depletion of tissue glutathione with diethyl maleate enhances hyperbaric oxygen toxicity. Am J Physiol (1990) 0.80
Gastrointestinal blood loss after diflunisal and after aspirin: effect of ethanol. Clin Pharmacol Ther (1978) 0.79
Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man. Drug Metab Dispos (1979) 0.79
Severe psoroptic mange and endoparasitism in a Nubian doe. Can Vet J (1994) 0.79
Cortisol treatment reduces ghrelin signaling and food intake in tilapia, Oreochromis mossambicus. Domest Anim Endocrinol (2012) 0.79
The chemistry, pharmacology and clinical pharmacology of diflunisal. Curr Med Res Opin (1978) 0.78
A double-blind comparison of a novel indanone diuretic (MK-196) with hydrochlorothiazide in the treatment of essential hypertension. Br J Clin Pharmacol (1979) 0.78
Isolated foveal retinoschisis as a cause of visual loss in young females. Br J Ophthalmol (2003) 0.78
Goal setting and control orientation of pregnant / parenting female adolescents in the GRADS program. Fam Consum Sci Res J (1995) 0.78
Contamination of disposable tonometer prisms during tonometry. Eye (Lond) (2006) 0.78
Pneumocystis carinii pneumonia diagnosed from sputum and successfully treated with pentamidine isethionate. Cancer (1970) 0.77
Bullous pemphigoid in a dog: treatment with six-mercaptopurine. J Am Vet Med Assoc (1984) 0.77
In vivo and in vitro metabolism studies on a class III antiarrhythmic agent. Drug Metab Dispos (1993) 0.77
Single-dose pharmacokinetics of 14C-lovastatin in chronic renal failure. Clin Pharmacol Ther (1991) 0.77
Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs. J Am Vet Med Assoc (1988) 0.76
Bioequivalence evaluation of new megestrol acetate formulations in humans. Semin Oncol (1985) 0.76
Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys. Drug Metab Dispos (1982) 0.76
Fetal surveillance in pregnancy complicated by diabetes mellitus: is it necessary? J Matern Fetal Neonatal Med (2002) 0.76
Tricyclic antidepressant poisoning. Practitioner (1970) 0.76
Effects of age on rat glutathione metabolism. Am J Med Sci (1991) 0.76
Improved reduction in pain in chronic pancreatitis with combined intraoperative celiac axis plexus block and lateral pancreaticojejunostomy. Curr Surg (2001) 0.75
Candida endophthalmitis presenting as bilateral posterior uveitis. J R Soc Med (1983) 0.75
Prolonged effect of antihypertensive agents. Br Med J (1974) 0.75
Proceedings: Haemodynamic effects of indoramin: a non-invasive technique for the cardiovascular evaluation of drugs. Br J Pharmacol (1972) 0.75
Protection from hyperbaric oxidant stress by administration of buthionine sulfoximine. J Appl Physiol (1985) (1991) 0.75
The use of diazepam in the treatment of tetanus. Am J Med Sci (1973) 0.75
Diseases of the lips and oral cavity of domestic animals. Clin Dermatol (1987) 0.75
Antihistamines. Postgrad Med (1970) 0.75
Transmission of leishmaniasis. J Am Vet Med Assoc (1989) 0.75
Oral chrysotherapy with auranofin in dogs. J Am Vet Med Assoc (1989) 0.75
Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes. Drug Metab Dispos (1989) 0.75
Facial dermatosis in four dogs with hyperadrenocorticism. J Am Vet Med Assoc (1986) 0.75
Localization of immunoglobulins and complement by the peroxidase antiperoxidase method in autoimmune and non-autoimmune canine dermatopathies. Vet Immunol Immunopathol (1987) 0.75
The evolution of star clusters: dynamics of star clusters. Science (1986) 0.75
Corynebacterium folliculitis in a horse. J Am Vet Med Assoc (1988) 0.75